X0407 4 2023-03-31 1 0001760764 G Medical Innovations Holdings Ltd. GMVD 0001535264 AWM Investment Company, Inc. 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022 0 0 1 0 0 Common Stock 2023-03-31 4 S 0 437500 1.0209 D 1000000 I By Limited Partnerships Common Stock 2023-04-03 4 S 0 300000 0.7276 D 700000 I By Limited Partnerships This is a weighted average price. AWM Investment Company, Inc., a Delaware corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (SSFQP), Special Situations Cayman Fund, L.P. (CAY), Special Situations Private Equity Fund, L.P. (SSPE), Special Situations Technology Fund, L.P. (TECH), Special Situations Technology Fund II, L.P. (TECH II) and Special Situations Life Sciences Fund, LP (SSLS). (SSLS and together with SSFQP, CAY, SSPE, TECH and TECH II, the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 289,100 shares of Common Stock of the Issuer (the Shares) held by SSFQP, 86,100 Shares held by Cay, 55,300 Shares held by SSPE, 25,200 Shares held by TECH, 137,200 Shares held by TECH II and 107,100 Shares held by SSLS. David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM. The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Adam Stettner 2023-04-04